Published in Circulation on August 03, 1999
Intramyocardial Delivery of Autologous Bone Marrow | NCT00820586
The role of vascular endothelial growth factor in wound healing. J Surg Res (2008) 2.68
Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest (2004) 2.06
Human studies of angiogenic gene therapy. Circ Res (2009) 1.92
Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am J Pathol (2002) 1.62
Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction. Proc Natl Acad Sci U S A (2012) 1.38
Myocardial gene delivery using molecular cardiac surgery with recombinant adeno-associated virus vectors in vivo. Gene Ther (2011) 1.21
Bone marrow cells recruited through the neuropilin-1 receptor promote arterial formation at the sites of adult neoangiogenesis in mice. J Clin Invest (2008) 1.20
Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease. J Am Coll Cardiol (2010) 1.17
Therapeutic myocardial angiogenesis. Microvasc Res (2007) 1.16
Vascular endothelial growth factor in heart failure. Nat Rev Cardiol (2013) 1.16
Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs. Proc Natl Acad Sci U S A (2007) 1.09
Cardiovascular gene therapy: current status and therapeutic potential. Br J Pharmacol (2007) 1.03
Adenovirus: the first effective in vivo gene delivery vector. Hum Gene Ther (2014) 1.02
A promising strategy for the treatment of ischemic heart disease: Mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats. Can J Cardiol (2007) 1.01
Protopanaxadiol and protopanaxatriol bind to glucocorticoid and oestrogen receptors in endothelial cells. Br J Pharmacol (2009) 0.97
Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium. Biomaterials (2010) 0.96
Cardiovascular Gene Therapy: Past, Present, and Future. Mol Ther (2017) 0.95
Current strategies for myocardial gene delivery. J Mol Cell Cardiol (2010) 0.95
Angiomyogenesis for myocardial repair. Antioxid Redox Signal (2009) 0.93
Far infra-red therapy promotes ischemia-induced angiogenesis in diabetic mice and restores high glucose-suppressed endothelial progenitor cell functions. Cardiovasc Diabetol (2012) 0.92
The evolution of heart gene delivery vectors. J Gene Med (2011) 0.92
Therapeutic angiogenesis for cardiovascular disease. Curr Control Trials Cardiovasc Med (2001) 0.89
Gene therapy in clinical medicine. Postgrad Med J (2004) 0.89
A realistic chance for gene therapy in the near future. Pediatr Nephrol (2004) 0.87
Concordant activity of transgene expression cassettes inserted into E1, E3 and E4 cloning sites in the adenovirus genome. J Gene Med (2009) 0.86
Non-invasive radioiodine imaging for accurate quantitation of NIS reporter gene expression in transplanted hearts. Eur J Cardiothorac Surg (2007) 0.85
MRI in guiding and assessing intramyocardial therapy. Eur Radiol (2005) 0.85
Designer blood vessels and therapeutic revascularization. Br J Pharmacol (2003) 0.84
Cardiovascular gene therapy for myocardial infarction. Expert Opin Biol Ther (2013) 0.83
The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure. Biophys Rev (2015) 0.83
Gene therapy to treat cardiac arrhythmias. Nat Rev Cardiol (2015) 0.83
Pharmacokinetic properties of 2nd-generation fibroblast growth factor-1 mutants for therapeutic application. PLoS One (2012) 0.82
Nonviral vector gene modification of stem cells for myocardial repair. Mol Med (2008) 0.82
The road ahead: working towards effective clinical translation of myocardial gene therapies. Ther Deliv (2014) 0.81
Development of viral vectors for use in cardiovascular gene therapy. Viruses (2010) 0.81
Effect of mini-tyrosyl-tRNA synthetase/mini-tryptophanyl-tRNA synthetase on ischemic angiogenesis in rats: proliferation and migration of endothelial cells. Heart Vessels (2010) 0.81
Non-viral VEGF(165) gene therapy--magnetofection of acoustically active magnetic lipospheres ('magnetobubbles') increases tissue survival in an oversized skin flap model. J Cell Mol Med (2008) 0.80
A needleless liquid jet injection delivery method for cardiac gene therapy: a comparative evaluation versus standard routes of delivery reveals enhanced therapeutic retention and cardiac specific gene expression. J Cardiovasc Transl Res (2014) 0.80
A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the "Antigen Capsid-Incorporation" strategy. Virol J (2014) 0.80
Long-term follow-up assessment of a phase 1 trial of angiogenic gene therapy using direct intramyocardial administration of an adenoviral vector expressing the VEGF121 cDNA for the treatment of diffuse coronary artery disease. Hum Gene Ther (2012) 0.79
Cardiovascular magnetic resonance imaging in delivering and evaluating the efficacy of hepatocyte growth factor gene in chronic infarct scar. Cardiovasc Revasc Med (2010) 0.79
Molecular imaging of angiogenesis after myocardial infarction by (111)In-DTPA-cNGR and (99m)Tc-sestamibi dual-isotope myocardial SPECT. EJNMMI Res (2015) 0.78
Different angiogenesis effect of mini-TyrRS/mini-TrpRS by systemic administration of modified siRNAs in rats with acute myocardial infarction. Heart Vessels (2010) 0.78
Gated SPECT imaging to detect changes in myocardial blood flow during progressive coronary occlusion. Int J Cardiovasc Imaging (2007) 0.78
Virus-mediated gene transfer to induce therapeutic angiogenesis: where do we stand? Int J Nanomedicine (2007) 0.78
Defining the success of cardiac gene therapy: how can nuclear imaging contribute? Eur J Nucl Med Mol Imaging (2003) 0.78
Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21. Am J Physiol Heart Circ Physiol (2015) 0.78
Neovascularization in tissue engineering. Cells (2012) 0.77
Factors determining heterogeneity in coronary collateral development: A clinical perspective. Exp Clin Cardiol (2002) 0.77
The NF-κB pathway: regulation of the instability of atherosclerotic plaques activated by Fg, Fb, and FDPs. Mol Cell Biochem (2013) 0.77
No hypoperfusion is produced in the epicardium during application of myocardial topical negative pressure in a porcine model. J Cardiothorac Surg (2007) 0.76
Distribution of intramyocardially injected extracellular MR contrast medium: effects of concentration and volume. Eur Radiol (2003) 0.76
Therapeutic Angiogenesis for Coronary Artery Disease. Curr Treat Options Cardiovasc Med (2002) 0.76
Differential expression of the isoforms of human vascular endothelial growth factor and new approaches to therapeutic angiogenesis. Dokl Biol Sci (2004) 0.76
Restenosis following coronary angioplasty: current status. Korean J Intern Med (2001) 0.75
Gene Therapy for Cardiovascular Disease. J Biomed Biotechnol (2003) 0.75
Stimulatory Influences of Far Infrared Therapy on the Transcriptome and Genetic Networks of Endothelial Progenitor Cells Receiving High Glucose Treatment. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2015) 0.75
Viral vectors for vascular gene therapy. Exp Clin Cardiol (2002) 0.75
Gene Therapy in Cardiac Surgery: Clinical Trials, Challenges, and Perspectives. Ann Thorac Surg (2016) 0.75
Liquid jet delivery method featuring S100A1 gene therapy in the rodent model following acute myocardial infarction. Gene Ther (2015) 0.75
The effect of astaxanthin on vascular endothelial growth factor (VEGF) levels and peroxidation reactions in the aqueous humor. J Clin Biochem Nutr (2016) 0.75
A compare between myocardial topical negative pressure levels of -25 mmHg and -50 mmHg in a porcine model. BMC Cardiovasc Disord (2008) 0.75
A Corticosteroid Gene Therapy Combination Strategy to Maximize Intramuscular-Mediated Delivery in Postischemic Myocardium. Hum Gene Ther Clin Dev (2015) 0.75
Angiogenic growth factors in myocardial infarction: a critical appraisal. Heart Fail Rev (2017) 0.75
Reprogramming cells for transplantation. Heart Fail Rev (2003) 0.75
Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol (1986) 18.40
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation (1977) 9.70
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med (2001) 9.53
Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet (1996) 7.84
Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med (1999) 6.93
Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol (1985) (1986) 6.86
Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol (1992) 6.51
Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med (1991) 6.08
Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol (1979) 5.94
Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. Nature (1992) 5.45
Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med (1976) 4.85
Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol (1992) 4.65
The SQUIRE (Standards for QUality Improvement Reporting Excellence) guidelines for quality improvement reporting: explanation and elaboration. Qual Saf Health Care (2008) 4.59
Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol (1989) 4.27
Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest (1977) 4.21
Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med (1981) 4.02
The relationship between 'job strain,' workplace diastolic blood pressure, and left ventricular mass index. Results of a case-control study. JAMA (1990) 4.00
Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. Circulation (1999) 3.82
Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med (1984) 3.73
Specific amino acid substitutions in bacterioopsin: Replacement of a restriction fragment in the structural gene by synthetic DNA fragments containing altered codons. Proc Natl Acad Sci U S A (1984) 3.67
Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol (1985) (1987) 3.51
Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival. Ann Intern Med (1991) 3.50
Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect Immun (1987) 3.45
Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest (1985) 3.40
Conservation of the regulatory subunit for the Clp ATP-dependent protease in prokaryotes and eukaryotes. Proc Natl Acad Sci U S A (1990) 3.33
Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med (2001) 3.25
Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet (1993) 3.22
Phytochrome E influences internode elongation and flowering time in Arabidopsis. Plant Cell (1998) 3.17
Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation (1987) 3.16
Life expectancy in the Marfan syndrome. Am J Cardiol (1995) 3.14
Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med (1981) 3.08
Access to coronary artery bypass surgery by race/ethnicity and gender among patients who are appropriate for surgery. Med Care (1999) 3.07
Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation (1996) 3.07
Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood (2001) 3.01
Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet (1989) 3.01
Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement. J Am Coll Cardiol (1999) 2.98
Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity. Nature (1986) 2.94
Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N Engl J Med (1987) 2.81
Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell Mol Biol (2000) 2.81
BRCA-associated breast cancer in young women. J Clin Oncol (1998) 2.78
Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA (1999) 2.74
Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med (1999) 2.74
Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol (1995) 2.74
Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med (1983) 2.71
Indian public-private partnership for skilled birth-attendance. Lancet (2008) 2.65
Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol (1984) 2.64
Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum Gene Ther (1997) 2.62
Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Engl J Med (1987) 2.62
Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J Clin Invest (1992) 2.62
Effect of wheat fiber and vitamins C and E on rectal polyps in patients with familial adenomatous polyposis. J Natl Cancer Inst (1989) 2.60
A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. N Engl J Med (1992) 2.57
The heart in hypertension. N Engl J Med (1992) 2.53
Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol (1985) 2.50
Evaluation of clinical parameters to predict Mycobacterium tuberculosis in inpatients. Arch Intern Med (2000) 2.46
The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci U S A (2000) 2.44
Gene therapy strategies for tumor antiangiogenesis. J Natl Cancer Inst (1998) 2.44
All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988. The Strong Heart Study. Am J Epidemiol (1998) 2.43
The psychological autopsy approach to studying suicide: a review of methodological issues. J Affect Disord (1998) 2.43
Phytochrome D acts in the shade-avoidance syndrome in Arabidopsis by controlling elongation growth and flowering time. Plant Physiol (1999) 2.42
Prognostic implications of left ventricular hypertrophy. Am Heart J (2001) 2.42
Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis. N Engl J Med (1986) 2.40
Molecular basis of alpha-1-antitrypsin deficiency. Am J Med (1988) 2.40
Predictors of mortality for patients undergoing cardiac valve replacements in New York State. Ann Thorac Surg (2000) 2.39
Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med (1986) 2.36
Bronchoalveolar lavage in interstitial lung disease. Ann Intern Med (1978) 2.36
Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc Natl Acad Sci U S A (1981) 2.34
Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis (2001) 2.34
Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization. J Clin Invest (1982) 2.33
Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J Clin Invest (1992) 2.33
Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med (1984) 2.30
Human type III collagen gene expression is coordinately modulated with the type I collagen genes during fibroblast growth. Biochemistry (1986) 2.28
Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders. J Clin Invest (1983) 2.27
Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells. Hum Gene Ther (1998) 2.27
Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med (1994) 2.26
Interleukin-8 gene expression in human bronchial epithelial cells. J Biol Chem (1991) 2.26
Rapid, nonradioactive detection of mutations in the human genome by allele-specific amplification. J Lab Clin Med (1989) 2.22
Cigarette smoking induces functional antiprotease deficiency in the lower respiratory tract of humans. Science (1979) 2.20
Sternal and costochondral infections following open-heart surgery. A review of 2,594 cases. J Thorac Cardiovasc Surg (1976) 2.20
Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J Clin Invest (1981) 2.20
Accurate quantification of cells recovered by bronchoalveolar lavage. Am Rev Respir Dis (1984) 2.17
Relations of left ventricular mass to fat-free and adipose body mass: the strong heart study. The Strong Heart Study Investigators. Circulation (1998) 2.14
Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis. N Engl J Med (1979) 2.13
Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J Exp Med (1997) 2.12
Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc Natl Acad Sci U S A (1991) 2.12
Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. Circulation (2000) 2.10
Intraluminal fibrosis in interstitial lung disorders. Am J Pathol (1986) 2.10
Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest (1981) 2.10
Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. The Percutaneous Excimer Laser Coronary Angioplasty Registry. Am J Cardiol (1992) 2.08
Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung. N Engl J Med (1980) 2.07
Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol (1991) 2.05
Mitral valve prolapse. Circulation (1976) 2.05
Aerosol alpha 1-antitrypsin treatment for cystic fibrosis. Lancet (1991) 2.05
Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization. J Clin Invest (1980) 2.04
Outcome analysis of 245 CarboMedics and St. Jude valves implanted at the same institution. Ann Thorac Surg (1998) 2.04
Safety of metallic surgical clips in patients undergoing high-field-strength magnetic resonance imaging. Ann Thorac Surg (1989) 2.03